Sponsor:
Mayo Clinic
Code:
NCT07407959
Conditions
Endometrial Carcinoma
Prostate Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Non-Interventional Study
Brief summary:
Conditions
Endometrial Carcinoma
Prostate Carcinoma
Study ID
NCT07407959
Start date
Sep 4, 2025
Status verified date
Feb, 2026
Completion date
Sep 30, 2028
Anticipated
Primary completion date
Sep 30, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
60 participants
Anticipated
Arms
Observational
Interventions
Non-Interventional Study
Primary outcome measure
Central contacts
Bobbie Ott
507-293-0922Locations
Mayo Clinic in Rochester
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Bobbie Ott
507-293-0922Principal Investigator:
Candice A. Bookwalter, MD, PhD
Sponsor
Mayo Clinic
Last update posted
Feb 17, 2026
Last verified
Feb, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-02-17.